A new class of fusion reactor
Our reliable and high-performance fusion reactor technology provides an analogue to the environment experienced in and around a functioning power reactor. From calibrating diagnostic equipment to shielding material testing.
How it works
Unlocking orders-of-magnitude-higher performance
Our systems produce two distinct fusion reactions in parallel with a single power input – fusion occurs in both the plasma and the solid-state lattice.
We call this novel reactor design Multi-State Fusion.
Through harnessing our latest understanding of stellar physics, we have already demonstrated the ability to increase the total fusion rate of our reactors by over an order of magnitude.
This is achieved by improving upon a TRL 9 reactor architecture by using proprietary methods to introduce fusion fuel into the solid plasma-facing internal components; TRL 6.
Compact, high-neutron flux and unparalleled lifetime output
By utilising lattice confinement fusion (LCF), a process validated by NASA in 2021, our reactor design achieves solid-state fuel densities 400 million times higher than those achievable in a plasma.
Deuterium-tritium fusions per second
produced within a commercial architecture. Fusion performance verified by members from external independent institutions.
times higher fuel density
than those achievable in a plasma with our patented reactor design, unlocking orders-of-magnitude-higher performance in a compact form factor.
of engineering design
and over 15 years of combined runtime as well as the latest understanding of stellar physics are the key to our core reactor architecture
More with less
Our reactor design benefits from an electron-screened environment within the core, thereby reducing the energy required to overcome the coulomb barrier between particles. This reduces the required temperatures to induce fusion by several million degrees.
Fuel densities 400 million times higher than the sun
Immediate medical and industrial applications
Our systems unlock a wide variety of medical, industrial, and research applications well before any fusion plant is plugged into the grid. We are developing innovative system designs to address global challenges such as those in health access and zero carbon energy.
Medical isotope production
We aim to provide medical isotope production at the point of care for both diagnostic and therapeutic applications. Our fusion-based alternative technology is more cost efficient, cleaner, safer and can be be situated near hospitals, dramatically reducing wait times and costs whilst improving quality of care.
Enabling fusion energy
Our reliable and high-performance compact fusion reactors are an ideal testbed for understanding what a full-scale fusion power plant will look like and how it might behave during operation; providing a tuneable and versatile platform for experimentation and high-quality data generation.
From Theory to Real World Applications
Over the years, Astral Systems has steadily advanced its Multi-State Fusion (MSF) technology, turning groundbreaking theory into a solution that delivers the promise of fusion already today.
Theory & Simulations
The first Multi-State fusion reactor is theorised, and detailed simulations and design analysis of combining LCF and IEC technologies indicate a significant performance gain.
First Prototype
Our first prototype reactor, built in the UK, demonstrated a 36% increase in reactor performance with limited fusion fuel enrichment in the solid state.
Second Round of Prototypes
The second round of prototypes, tested in partnership with the University of Bristol, yielded in excess of an order of magnitude increase in fusion performance. This allows us to confidently produce greater than 100 billion DT fusions per second within a compact commercial architecture.
Verified Performance
Third round of prototypes being tested at Astral's facility in the UK with members from external independent institutions verifying fusion performance. This allows us to confidently produce greater than 1 trillion DT fusions per second within a commercial architecture. The performance is highly relevant to our approach to decentralized medical isotope production.
A wide range of applications and capabilities
As we progress the fusion rate of our technology, aiming to exceed 10 trillion DT fusions per second per system, we unlock a wide range of applications and capabilities, such as large-scale medical isotope production, fusion neutron materials damage testing, transmutation of existing nuclear waste stores, space applications, hybrid fusion-fission power systems, and beyond.
Unlock the power of multi-state fusion